Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
0.9765
-0.0150 (-1.51%)
Oct 30, 2026, 4:00 PM EST - Market closed
Fractyl Health Employees
Fractyl Health had 100 employees as of December 31, 2025. The number of employees decreased by 7 or 6.54% compared to the previous year. That makes Fractyl Health the 31,480th largest employer in the world and 4,037th in the United States.
Employees
100
Change (1Y)
-7
Growth (1Y)
-6.54%
Revenue / Employee
n/a
Profits / Employee
-$1,056,500
Market Cap
12.95M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 100 | -7 | -6.54% |
| Sep 30, 2025 | 101 | -21 | -17.21% |
| Jun 30, 2025 | 103 | -9 | -8.04% |
| Mar 31, 2025 | 109 | -2 | -1.80% |
| Dec 31, 2024 | 107 | 5 | 4.90% |
| Sep 30, 2024 | 122 | 34 | 38.64% |
| Jun 30, 2024 | 112 | 19 | 20.43% |
| Mar 31, 2024 | 111 | 18 | 19.35% |
| Dec 31, 2023 | 102 | - | - |
| Sep 30, 2023 | 88 | - | - |
| Jun 30, 2023 | 93 | - | - |
| Dec 31, 2021 | 83 | - | - |
| Sep 30, 2021 | 73 | - | - |
| Jun 30, 2021 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| aTyr Pharma | 60 |
| Cerenome | 28 |
| Daré Bioscience | 24 |
| Bolt Biotherapeutics | 23 |
| BioCardia | 21 |
| Psyence Biomedical | 12 |
| AEON Biopharma | 8 |
| Allarity Therapeutics | 8 |
GUTS News
- 2 days ago - Fractyl Health Strengthens Revita Patent Portfolio as It Advances Toward FDA Submission and Potential Commercialization - GlobeNewsWire
- 3 days ago - Fractyl Health Announces Market Research Highlighting Substantial Patient Interest in a One-Time Procedural Approach to Post-GLP-1 Weight Maintenance - GlobeNewsWire
- 10 days ago - Fractyl Health cuts about 45% of workforce to focus on Revita - TheFly
- 10 days ago - Fractyl Health ends Rejuva development, sees cash runway into Q2 2027 - TheFly
- 10 days ago - Fractyl Health co-founder Jay Caplan to retire, continue as advisor - TheFly
- 10 days ago - Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance - GlobeNewsWire
- 12 days ago - Fractyl Health price target lowered to $39 from $96 at Canaccord - TheFly
- 13 days ago - Fractyl Health price target lowered to $5 from $48 at Craig-Hallum - TheFly